Our patent examiners have prepared these searches related to patents or patent applications for vaccines against coronaviruses which you can explore for yourself:
Patent analytics gives a deeper dive into the patent landscape. Our patent analysts have created a spreadsheet containing all the search strategies, datasets for vaccines against coronavirus patents and additional statistics in one place for you to download. You can also run the search strategies on your own platform or analyse the datasets yourself. If you are not familiar with how to write or adapt search strategies, our Espacenet pocket guide will help.
The following queries provide an overview of small organic-molecule/peptide based therapies for coronavirus, resulting from the intersection of key-word search terms for the disease and the IPC and CPC classes A61K31, A61K38 and A61K45/06 for the compounds. Antibodies and nucleic acids are not included in this analysis, see the fourth accordion below: “Nucleic acids and antibodies to fight coronavirus”.
For a general overview of candidate therapies for diseases caused by coronaviruses in general, see here:
Patent analytics gives a deeper dive into the patent landscape. Our patent analysts have created a spreadsheet containing all the search strategies and datasets for patents for candidate therapies for fighting diseases caused by coronaviruses, as well as additional statistics in one place for you to download. You can also run the search strategies on your own platform or analyse the datasets yourself. If you are not familiar with how to write or adapt search strategies, our Espacenet pocket guide will help.
The following section contains a selection of small organic-molecule/peptide based antiviral drug candidates with potential activity against SARS-CoV-2. Appearance of a compound in the list does not imply any assessment on effectiveness. Because research is rapidly evolving, this list is non-exhaustive. The focus was set on compounds that are advanced in clinical trials. The hits retrieved for a specific query contain patent families relating to the specific drug and also to drugs with a similar chemical structure which are classified in the same class. This is a consequence of the “OR” operator between the classes and key-words used.
The following section contains a selection of small organic-molecule/peptide based drug candidates which may potentially have a beneficial effect on the symptoms of SARS-CoV-2 in infected patients. This list does not cover therapeutics for post-COVID conditions, but rather focuses on acute symptomatic COVID-19 therapies. Appearance of a compound in the list does not imply any assessment on effectiveness. Because research is rapidly evolving, this list is non-exhaustive. The hits retrieved for a specific query contain patent families relating to the specific drug and also to drugs with a similar chemical structure which are classified in the same class. This is a consequence of the “OR” operator between the classes and key-words used. (Each of the listed drug candidates includes a hyperlink to Espacenet and the search statement)
Patent analytics gives a deeper dive into the patent landscape. Our patent analysts have created a spreadsheet containing all the search strategies and datasets for patents for antiviral and symptomatic therapeutics for fighting coronavirus, as well as additional statistics in one place for you to download. You can also run the search strategies on your own platform or analyse the datasets yourself.
If you are not familiar with how to write or adapt search strategies, our Espacenet pocket guide will help.
The following section identifies classes of nucleic acid molecules that interfere with the coronavirus infection or mediate the immune response induced by the viral infection. Antisense, small interfering RNA or nucleic acids that associate with a nuclease (CRISPR/Cas) directly inactivate the viral expression and/or replication. Aptamers bind to and inactivate viral or cellular proteins, thereby inhibiting coronavirus infection. The immunomodulatory nucleic acid do not act directly on the virus but modulate the immune anti-viral response. (Each of the listed classes of nucleic acid molecules includes a hyperlink to Espacenet and the search statement)
The following query identifies antibodies against coronaviruses and their use in therapy. These antibodies inhibit either receptor binding and/or viral entry or induce the elimination of infected cells.
Patent analytics gives a deeper dive into the patent landscape. Our patent analysts have created a spreadsheet containing all the search strategies and datasets for patents for nucleic acids and antibodies for fighting coronavirus, as well as additional statistics in one place for you to download. You can also run the search strategies on your own platform or analyse the datasets yourself. If you are not familiar with how to write or adapt search strategies, our Espacenet pocket guide will help.
The use of the EPO’s website, downloads, data and information tools are subject to the EPO’s standard terms and conditions. See especially the terms of use for Espacenet.
